Sensyne Health PLC (LON:SENS) said it has made two key senior hires.
Hina Zaman has been appointed managing director of the healthcare division, while Martin Gouldstone will fill the role of chief business officer of the life sciences division.
Zaman joins from Babylon Health and will focus on the commercialisation of Sensyne’s clinical AI software for remote patient monitoring and decision-making support.
Gouldstone is moving from Syneos and will be responsible for expanding the company’s pharmaceutical industry partnerships as well as looking at potential growth areas, including M&A opportunities.
In a statement, Sensyne chief executive Lord Drayson said: "I'm delighted to welcome Hina and Martin to Sensyne. They bring deep experience and strong personal networks that further strengthen Sensyne's excellent leadership team and increase our capacity to manage the significant growth we expect to deliver over the coming years."